Avastin and Ampyra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avastin (bevacizumab) and Ampyra (dalfampridine). Common drug interactions include acute myocardial infarction among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Avastin and Ampyra. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Avastin?

Avastin has active ingredients of bevacizumab. It is often used in high blood cholesterol. eHealthMe is studying from 76,365 Avastin users. Check the latest studies of Avastin.

What is Ampyra?

Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.



On Jul, 13, 2026

12 people who take Avastin and Ampyra together, and have interactions are studied.

Avastin and Ampyra drug interactions.

What are the common drug interactions of Avastin and Ampyra, by gender? *:

female:

  1. Acute myocardial infarction (acute heart attack)
  2. Depressed mood
  3. Fatigue (feeling of tiredness)
  4. Injection site erythema (redness at injection site)
  5. Skin cancer
  6. Bradycardia (abnormally slow heart action)
  7. Nausea (feeling of having an urge to vomit)
  8. Asthenia (weakness)
  9. Balance disorder
  10. Decreased appetite

male:

  1. Drug hypersensitivity
  2. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  3. Burns third degree
  4. Hepatotoxicity (chemical-driven liver damage)
  5. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Nerve injury
  8. Pneumonia

What are the common drug interactions of Avastin and Ampyra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Bradycardia (abnormally slow heart action)
  2. Nausea (feeling of having an urge to vomit)
  3. Lung adenocarcinoma (a form of non-small cell lung cancer)

60+:

  1. Drug hypersensitivity
  2. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  3. Fatigue (feeling of tiredness)
  4. Hepatotoxicity (chemical-driven liver damage)
  5. Injection site erythema (redness at injection site)
  6. Injection site pain
  7. Injection site pruritus (severe itching at injection site)
  8. Injection site streaking
  9. Injection site swelling
  10. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

What are the existing conditions these people have? *

  1. Gait Disturbance: 5 people, 41.67%
  2. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Avastin and Ampyra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Avastin and Ampyra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Avastin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ampyra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avastin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ampyra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bevacizumab and dalfampridine (the active ingredients of Avastin and Ampyra, respectively), and Avastin and Ampyra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: